Pila Pharmas new scientific adviser comments on the obesity development
18 december, 14:15
18 december, 14:15
Pila Pharma recently strengthened its scientific advisory board with a significant addition: Professor Thomas Lutz, a renowned expert in metabolic research and the pancreatic hormone amylin. As the company approaches key preclinical proof-of-concept results for its candidate XEN-D0501, BioStock reached out to Professor Lutz to discuss his decision to join, his view on the obesity market, and the potential of Pila Pharma's novel approach.
Read the full article at biostock.se:
https://biostock.se/en/2025/12/pila-pharmas-nya-vetenskaplige-radgivare-kommenterar-utvecklingen-inom-fetmaomradet/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
18 december, 14:15
Pila Pharma recently strengthened its scientific advisory board with a significant addition: Professor Thomas Lutz, a renowned expert in metabolic research and the pancreatic hormone amylin. As the company approaches key preclinical proof-of-concept results for its candidate XEN-D0501, BioStock reached out to Professor Lutz to discuss his decision to join, his view on the obesity market, and the potential of Pila Pharma's novel approach.
Read the full article at biostock.se:
https://biostock.se/en/2025/12/pila-pharmas-nya-vetenskaplige-radgivare-kommenterar-utvecklingen-inom-fetmaomradet/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.

Analys
Saab kammar hem miljardordrar

Guldrallyt
Fonder

Bolån



Analys
Saab kammar hem miljardordrar

Guldrallyt
Fonder

Bolån


SBB Norden D
25 december, 07:00
Reportagen från 2025 du inte får missa
OMX Stockholm 30
1 DAG %
Senast
2 849,09